TVM Capital Life Science

Investor type

PE

Founded

1984

AUM

-

Location

United Arab Emirates

$10-50 m

Investment Ticket

3-5 years

Investment Horizon

Series B, Series A

Investment Stage

Sale to strategic investor, IPO

Exit Strategy

Investor profile last updated: 06 December, 2025

Profile

TVM Capital Healthcare is a globally active healthcare private equity firm with emerging markets strength. We bring over 35 years of international healthcare investment experience to some of the fastest-growing healthcare markets in the world and are uniquely placed to connect East and West; with local skills and abilities on-the-ground across Southeast Asia, and the MENAT region to help transformational healthcare companies to execute on their growth plans.

Industry

Healthcare Services Biotechnology Marketing and Advertising Medical Devices Pharmaceuticals Real Estate Robotics MedTech Life Sciences Infrastructure HealthTech AdTech

Region of investment

North America Europe Middle East Africa Asia

Contacts

Upgrade to see contacts
Name
Title
Email
avatar
sY8lU4dvRpKwCOta sY8lU4dvRpKwCOta
sY8lU4dvRpKwCOta
avatar
sY8lU4dvRpKwCOta sY8lU4dvRpKwCOta
sY8lU4dvRpKwCOta
avatar
sY8lU4dvRpKwCOta sY8lU4dvRpKwCOta
sY8lU4dvRpKwCOta
avatar
sY8lU4dvRpKwCOta sY8lU4dvRpKwCOta
sY8lU4dvRpKwCOta
avatar
sY8lU4dvRpKwCOta sY8lU4dvRpKwCOta
sY8lU4dvRpKwCOta
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!

FAQs about TVM Capital Life Science

TVM Capital Life Science is located in United Arab Emirates.
TVM Capital Life Science was founded in 1984.
TVM Capital Life Science invests in companies and startups in Healthcare Services, Biotechnology, Marketing and Advertising, Medical Devices, Pharmaceuticals, Real Estate, Robotics, MedTech, Life Sciences, Infrastructure, HealthTech, AdTech.
TVM Capital Life Science invests in companies and startups in North America, Europe, Middle East, Africa, Asia.
TVM Capital Life Science invests in companies and startups at Series B, Series A.
TVM Capital Life Science usually invests $10-50 m on average.